Accueil   Diary - News   All news Poxel Appoints Kumi Sato to its Board of Directors

Poxel Appoints Kumi Sato to its Board of Directors

LYON, France--(BUSINESS WIRE)-- POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, today announced the addition of Kumi Sato, President and CEO of COSMO Public Relations Corporation, to its Board of Directors.


Ms. Sato is a seasoned executive with over 30 years’ experience advising companies in business and communication strategy, with a particular focus on Japanese business strategies for healthcare companies. The appointment was approved by Poxel’s shareholders at the Annual Shareholder Meeting, which was held in Paris on Friday, June 30, 2017.



Read the press release